Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer von SCHER, Howard I, XIAOYU JIA, MELUCH, Anthony A, NORDQUIST, Luke T, VENNER, Peter M, HEIDENREICH, Axel, CHU, Luis, HELLER, Glenn, CHI, Kim, DE WIT, Ronald, BERRY, William R, ALBERS, Peter, HENICK, Brian, WATERHOUSE, David, RUETHER, Dean J, ROSEN, Peter J

Volltext

Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Invest... von BEER, Tomasz M, RYAN, Christopher W, CARDUCCI, Michael A, VICARIO, Daniel, DREICER, Robert, HIGANO, Celestia S, AHMANN, Frederick R, CHI, Kim N, HENNER, W. David, ARROYO, Alan, CLOW, Fong W, VENNER, Peter M, PETRYLAK, Daniel P, CHATTA, Gurkamal S, RUETHER, J. Dean, REDFERN, Charles H, FEHRENBACHER, Louis, SALEH, Mansoor N, WATERHOUSE, David M

Volltext

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy von Beer, Tomasz M, Armstrong, Andrew J, Rathkopf, Dana E, Loriot, Yohann, Sternberg, Cora N, Higano, Celestia S, Iversen, Peter, Bhattacharya, Suman, Carles, Joan, Chowdhury, Simon, Davis, Ian D, de Bono, Johann S, Evans, Christopher P, Fizazi, Karim, Joshua, Anthony M, Kim, Choung-Soo, Kimura, Go, Mainwaring, Paul, Mansbach, Harry, Miller, Kurt, Noonberg, Sarah B, Perabo, Frank, Phung, De, Saad, Fred, Scher, Howard I, Taplin, Mary-Ellen, Venner, Peter M, Tombal, Bertrand

Volltext

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer von SEGAL, Roanne J, REID, Robert D, WELLS, George A, COURNEYA, Kerry S, MALONE, Shawn C, PARLIAMENT, Matthew B, SCOTT, Chris G, VENNER, Peter M, QUINNEY, H. Arthur, JONES, Lee W, SLOVINEC D'ANGELO, Monika E

Volltext

Intermittent versus Continuous Androgen Deprivation in Prostate Cancer von Hussain, Maha, Tangen, Catherine M, Berry, Donna L, Higano, Celestia S, Crawford, E. David, Liu, Glenn, Wilding, George, Prescott, Stephen, Kanaga Sundaram, Subramanian, Small, Eric Jay, Dawson, Nancy Ann, Donnelly, Bryan J, Venner, Peter M, Vaishampayan, Ulka N, Schellhammer, Paul F, Quinn, David I, Raghavan, Derek, Ely, Benjamin, Moinpour, Carol M, Vogelzang, Nicholas J, Thompson, Ian M

Volltext

Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors von Courneya, Kerry S., Segal, Roanne J., Reid, Robert D., Jones, Lee W., Malone, Shawn C., Venner, Peter M., Parliament, Matthew B., Scott, Chris G., Quinney, H.Arthur, Wells, George A.

Volltext

A Randomized Phase II and Pharmacokinetic Study of the Antisense Oligonucleotides ISIS 3521 and ISIS 5132 in Patients with Hormone-refractory Prostate Cancer von Tolcher, Anthony W, Reyno, Leonard, Venner, Peter M, Ernst, Scott D, Moore, Malcolm, Geary, Richard S, Chi, Kim, Hall, Sean, Walsh, Wendy, Dorr, Andrew, Eisenhauer, Elizabeth

Volltext

A population-based study examining the effect of tyrosine kinase inhibitors on survival in metastatic renal cell carcinoma in Alberta and the role of nephrectomy prior to treatment von Warren, Mark, Venner, Peter M, North, Scott, Cheng, Tina, Venner, Chris, Ghosh, Sunita, Venner, Allison A, Finch, Daygen

Volltext

The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial von Bjarnason, Georg A., Knox, Jennifer J., Kollmannsberger, Christian K., Soulieres, Denis, Ernst, D. Scott, Zalewski, Pawel, Canil, Christina M., Winquist, Eric, Hotte, Sebastien J., North, Scott A., Heng, Daniel Yick Chin, Macfarlane, Robyn Jane, Venner, Peter M., Kapoor, Anil, Hansen, Aaron R., Eigl, Bernhard J., Czaykowski, Piotr, Boyd, Ben, Wang, Lisa, Basappa, Naveen S.

Volltext

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plu... von Beer, Tomasz M, Ryan, Christopher W, Venner, Peter M, Petrylak, Daniel P, Chatta, Gurkamal S, Ruether, J Dean, Chi, Kim N, Young, James, Henner, W David

Volltext

Safety and Efficacy of the Multidrug-Resistance Inhibitor Biricodar (VX-710) with Concurrent Doxorubicin in Patients with Anthracycline-resistant Advanced Soft Tissue Sarcoma von BRAMWELL, Vivien H. C, MORRIS, Donald, ERNST, D. Scott, HINGS, Ingrid, BLACKSTEIN, Martin, VENNER, Peter M, ETTE, Ene I, HARDING, Matthew W, WAXMAN, Allison, DEMETRI, George D

Volltext

Prostate-specific antigen doubling time is associated with survival in men with hormone-refractory prostate cancer von Semeniuk, Ross C., Venner, Peter M., North, Scott

Volltext

High dose calcitriol may reduce thrombosis in cancer patients von Beer, Tomasz M., Venner, Peter M., Ryan, Christopher W., Petrylak, Daniel P., Chatta, Gurkamal, Dean Ruether, J., Chi, Kim N., Curd, John G., DeLoughery, Thomas G.

Volltext

A prospective study of the determinants of exercise in bladder cancer survivors using the Theory of Planned Behavior von Karvinen, Kristina H., Courneya, Kerry S., Plotnikoff, Ronald C., Spence, John C., Venner, Peter M., North, Scott

Volltext

Phase II study of individualized sunitinib as first-line therapy for metastatic renal cell cancer (mRCC) von Bjarnason, Georg A., Knox, Jennifer J., Kollmannsberger, Christian K., Soulieres, Denis, Ernst, D. Scott, Canil, Christina M., Winquist, Eric, Zalewski, Pawel, Hotte, Sebastien J., North, Scott A., Heng, Daniel Yick Chin, Macfarlane, Robyn Jane, Venner, Peter M., Tannock, Ian, Kapoor, Anil, Eigl, Bernhard J., Hansen, Aaron Richard, Czaykowski, Piotr, Boyd, Ben, Basappa, Naveen S.

Volltext

Comparison of goserelin and leuprolide in combined androgen blockade therapy von Sarosdy, Michael F, Schellhammer, Paul F, Sharifi, Roohollah, Block, Norman L, Soloway, Mark S, Venner, Peter M, Patterson, A.Lynn, Vogelzang, Nicholas J, Chodak, Gerald W, Klein, Eric A, Jones Schellenger, Julie, Kolvenbag, Geert J.C.M

Volltext

High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience von Zhang, Hanbo, Alimohamed, Nimira S, Basappa, Naveen S, Cheng, Tina, Chu, Michael, Cox-Kennett, Nanette, Ernst, D Scott, Fontaine, Amelie, Ghosh, Sunita, Heng, Daniel Y C, Littleton, Richard, North, Scott, Railton, Cindy, Sandhu, Irwindeep, Stenson, Trevor H, Stewart, Douglas A, Venner, Christopher P, Venner, Peter, Kolinsky, Michael P

Volltext

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors von Scrimger, Rufus A, Murtha, Albert D, Parliament, Matthew B, Venner, Peter M, Hanson, John, Houle, Greg, Chetner, Michael

Volltext

High-dose chemotherapy with autologous stem cell transplantation (HDC-ASCT) for relapsed metastatic germ cell tumors (mGCTs): The Alberta experience from 2001 to 2018 von Zhang, Hanbo, Alimohamed, Nimira S., Basappa, Naveen S., Cheng, Tina, Chu, Michael, Cox-Kennett, Nanette, Ernst, D. Scott, Fontaine, Amelie, Ghosh, Sunita, Heng, Daniel Yick Chin, Littleton, Richard, North, Scott A., Railton, Cindy, Sandhu, Irwindeep, Stewart, Douglas Allan, Venner, Chris, Venner, Peter M., Kolinsky, Michael Paul

Volltext

Salvage high-dose chemotherapy for primary mediastinal nonseminomatous germ cell tumors: Single institute experience von Walker, John WT, North, Scott A., Basappa, Naveen S., Venner, Peter M.

Volltext